Company / Operating Cash Flow per Share
Enveric Biosciences, Inc. Operating Cash Flow per Share History
FY2017-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.52
FY2019
5-year range
-$1.52 / -$0.15
FY2017-FY2019
Trend
-904.1%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share changed -904% YoY in FY2019, a notable deviation from the 2-year average annual change of -441%.
Based on SEC 10-K filings.
-1.52 in FY2019.
Declined from $-0.19 to $-1.52 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, operating cash flow per share decreased 904.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | -$1.52 | -904.1% |
| FY2018 | -$0.15 | +22.5% |
| FY2017 | -$0.19 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026